Moderna’s personalized mRNA shot could reshape the fight against skin cancer — but it may also be overhyped
MarketWatch· Jaimy Lee· Aug 20, 2026 · 7:01 PM
Doctors and patients are excited about the possible breakthrough, but some analysts believe there’s too much hype.
This is a summary. Read the complete story at MarketWatch below.
Read full article at MarketWatchRelated Stories
marketsabout 4 hours ago
‘I want to make her proud’: My mother, a divorcée, died and I’m her executor. Do I need to file for probate?
“The only debts were utility and credit-card bills, which we will pay off.”
MarketWatch
marketsabout 12 hours ago
Micron could dethrone Nvidia and become the biggest driver of S&P 500 profit growth
Micron is increasingly important to the S&P 500, and its earnings report has become “a market event in and of itself.”
MarketWatch
marketsabout 13 hours ago
Look closer, and Wall Street’s rally is showing cracks
Major stock indexes hovering near records are masking a market straining under elevated oil prices, rising Treasury yields and a Federal Reserve bracing for additional interest-rate hikes.
MarketWatch